Viewing Study NCT05763160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-29 @ 3:02 AM
Study NCT ID: NCT05763160
Status: COMPLETED
Last Update Posted: 2023-11-18
First Post: 2023-02-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Study That Will Test a Second Treatment Session of RZL-012.
Sponsor: Raziel Therapeutics Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module